Showing results (191-200 of 315) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|May 21, 2009
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954S O Vass, D Jarrom, W R Wilson, et al.The Journal of Clinical Investigation|September 1, 1975
Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenonJ J Lertora, A L Mark, J Johannsen, et al.Annual Review of Medicine|January 1, 1997
Infective endocarditis caused by HACEK microorganismsM Das, A D Badley, F R Cockerill, et al.Mayo Clinic Proceedings|November 1, 1980
Toxic shock syndrome, a newly recognized disease entity. Report of 11 casesU G McKenna, J A Meadows, N S Brewer, et al.Antimicrobial Agents and Chemotherapy|February 27, 1999
Ketolide treatment of Haemophilus influenzae experimental pneumoniaK E Piper, M S Rouse, J M Steckelberg, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771W R Wilson, J W Moselen, S Cliffe, et al.American Journal of Clinical Pathology|August 1, 1982
The antimicrobial removal device. A microbiological and clinical evaluationA J Wright, R L Thompson, C A McLimans, et al.Antimicrobial Agents and Chemotherapy|December 1, 1996
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococciC M Brandt, C B Warner, M S Rouse, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 26, 2009
Evaluation of antibiotic therapy following valve replacement for native valve endocarditisH J Fadel, I M Tleyjeh, J M Steckelberg, et al.Pageof 32